Search Results - RIFAMPIN

1

Academic Journal

A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.

Authors: Bobba, Suhas^1,2 (AUTHOR), Chauhan, Kuldeep S.³ (AUTHOR), Akter, Sadia³ (AUTHOR), Das, Shibali¹ (AUTHOR), Mittal, Ekansh² (AUTHOR), Mathema, Barun⁴ (AUTHOR), Philips, Jennifer A.^1,2 (AUTHOR), Khader, Shabaana A.³ (AUTHOR) khader@uchicago.edu

Superior Title: PLoS Pathogens. 4/11/2024, Vol. 20 Issue 4, p1-22. 22p.

Subject Terms: *RIFAMPIN, *TYPE I interferons, *MYCOBACTERIUM tuberculosis, *MYCOBACTERIAL diseases, *MYELOID cells, *CELL physiology, *RNA polymerases

HTML Full Text PDF Full Text

2

Academic Journal

Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.

Authors: Tesfahun, Hiwot Melak¹ (AUTHOR), Al-Salihi, Layth² (AUTHOR), Abdulkareem Al-Ani, Nadia² (AUTHOR), Mankhi, Ahmed Asmer² (AUTHOR), Mohammed, Ammar³ (AUTHOR), Lim, Chenery Ann E.³ (AUTHOR), Al-Hilfi, Riadh Abdulameer⁴ (AUTHOR), Jouego, Christelle G.⁵ (AUTHOR) chjouego@itg.be, Decroo, Tom⁶ (AUTHOR), Moussally, Krystel⁷ (AUTHOR), Ferlazzo, Gabriella⁸ (AUTHOR), Isaakidis, Petros^8,9 (AUTHOR)

Superior Title: PLoS ONE. 1/19/2024, Vol. 19 Issue 1, p1-14. 14p.

Subject Terms: *RIFAMPIN, *TUBERCULOSIS, *TREATMENT effectiveness, *MEDICAL care, *LOGISTIC regression analysis, *WAR

Geographic Terms: IRAQ

Company/Entity: WORLD Health Organization

HTML Full Text PDF Full Text

3

Academic Journal

Tuberculosis Diagnosis and Detection of Drug Resistance: A Comprehensive Updated Review.

Authors: Tawfick, Mahmoud M.^1,2 mahmoud_tawfick@azhar.edu.eg, Badawy, Mona Shaban E. M.³, Taleb, Mohammed H.⁴, Menofy, Nagwan G. El³

Superior Title: Journal of Pure & Applied Microbiology. 2023, Vol. 17 Issue 4, p1978-2009. 32p.

Subject Terms: *RIFAMPIN, *EXTRAPULMONARY tuberculosis, *NUCLEIC acid amplification techniques, *DRUG resistance, *TUBERCULOSIS, *ANTITUBERCULAR agents

Company/Entity: CENTERS for Disease Control & Prevention (U.S.)

PDF Full Text

4

Academic Journal

Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.

Authors: Trivedi, Priyanka¹ (AUTHOR), Chaturvedi, Vinita¹ (AUTHOR) vinita_chaturvedi@cdri.res.in

Superior Title: PLoS ONE. 11/30/2023, Vol. 18 Issue 11, p1-19. 19p.

Subject Terms: *HYDROXYTYROSOL, *RIFAMPIN, *CONCOMITANT drugs, *TUBERCULOSIS, *DRUGS, *SITAGLIPTIN, *NIFEDIPINE

HTML Full Text PDF Full Text

5

Academic Journal

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.

Authors: Chawangwa Modongo¹, Barilar, Ivan², Qiao Wang^3,4, Tuduetso Molefi⁵, Topo Makhondo⁵, Niemann, Stefan^3,6, Shin, Sanghyuk S.^2,3 ssshin2@uci.edu

Superior Title: Emerging Infectious Diseases. Nov2023, Vol. 29 Issue 11, p2403-2406. 4p.

Subject Terms: *RIFAMPIN, *TUBERCULOSIS, *DIAGNOSTIC errors, *PUBLIC health

Geographic Terms: BOTSWANA

PDF Full Text

6

Academic Journal

Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.

Authors: Mushtaq, Fizza^1,2 (AUTHOR), Raza, Syed Mohsin¹ (AUTHOR), Ahmad, Adeel³ (AUTHOR), Aslam, Hina¹ (AUTHOR), Adeel, Atiqa³ (AUTHOR), Saleem, Sidrah³ (AUTHOR), Ahmad, Irfan^1,2 (AUTHOR) irfan.ahmad@umu.se

Superior Title: PLoS ONE. 10/26/2023, Vol. 18 Issue 10, p1-14. 14p.

Subject Terms: *RIFAMPIN, *ANTI-infective agents, *MYCOBACTERIUM tuberculosis, *TREATMENT failure, *MOXIFLOXACIN, *VERAPAMIL

Geographic Terms: LAHORE (Pakistan)

HTML Full Text PDF Full Text

7

Academic Journal

Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.

Authors: Malhotra, Akash¹ (AUTHOR), Thompson, Ryan¹ (AUTHOR), De Vos, Margaretha² (AUTHOR), David, Anura³ (AUTHOR), Schumacher, Samuel⁴ (AUTHOR), Sohn, Hojoon⁵ (AUTHOR) hsohn@snu.ac.kr

Superior Title: PLoS ONE. 8/24/2023, Vol. 18 Issue 8, p1-11. 11p.

Subject Terms: *RIFAMPIN, *RESOURCE-limited settings, *NUCLEIC acid amplification techniques, *TUBERCULOSIS, *COST analysis

Company/Entity: WORLD Health Organization

HTML Full Text PDF Full Text

8

Academic Journal

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.

Authors: Katamba, Achilles¹ (AUTHOR) willyssengooba@gmail.com, Ssengooba, Willy^2,3,4 (AUTHOR) willyssengooba@gmail.com, Sserubiri, James^2,4 (AUTHOR), Semugenze, Derrick^2,4 (AUTHOR), Kasule, George William⁵ (AUTHOR), Nyombi, Abdunoor⁵ (AUTHOR), Byaruhanga, Raymond⁵ (AUTHOR), Turyahabwe, Stavia⁵ (AUTHOR), Joloba, Moses L.^2,4,5 (AUTHOR)

Superior Title: PLoS ONE. 8/17/2023, Vol. 18 Issue 8, p1-9. 9p.

Subject Terms: *RIFAMPIN, *MYCOBACTERIUM tuberculosis, *SENSITIVITY & specificity (Statistics), *ERROR rates, *ISONIAZID, *FLUOROQUINOLONES, *TRAINING needs

Geographic Terms: UGANDA

HTML Full Text PDF Full Text

9

Academic Journal

Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion: an in-vitro and ex-vivo investigation.

Authors: Nair, Athira R.¹ (AUTHOR), Vullendula, Sai Krishna Anand¹ (AUTHOR), Yarlagadda, Dani Lakshman¹ (AUTHOR), Bheemisetty, Brahmam² (AUTHOR), Dengale, Swapnil J.³ (AUTHOR), Bhat, Krishnamurthy¹ (AUTHOR) km.bhat@manipal.edu

Superior Title: Drug Development & Industrial Pharmacy. Mar2024, Vol. 50 Issue 3, p192-205. 14p.

Subject Terms: RITONAVIR, RIFAMPIN, DISPERSION (Chemistry), CONCOMITANT drugs, FLUORESCENCE spectroscopy, MOLE fraction, SUPERSATURATION, DRUG solubility

Zugang prüfen (DOI)

10

Academic Journal

Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.

Authors: Moga, Shewki^1,2 (AUTHOR) shewki2002@gmail.com, Bobosha, Kidist³ (AUTHOR), Fikadu, Dinka¹ (AUTHOR), Zerihun, Betselot¹ (AUTHOR), Diriba, Getu¹ (AUTHOR), Amare, Misikir¹ (AUTHOR), Kempker, Russell R.⁴ (AUTHOR), Blumberg, Henry M.^4,5 (AUTHOR), Abebe, Tamrat² (AUTHOR)

Superior Title: PLoS ONE. 4/26/2023, Vol. 17 Issue 4, p1-11. 11p.

Subject Terms: *RIFAMPIN, *MYCOBACTERIUM tuberculosis, *ISONIAZID, *GENOTYPES, *FISHER exact test, *PROMOTERS (Genetics), *DRUG resistance

Geographic Terms: ETHIOPIA

HTML Full Text PDF Full Text

11

Academic Journal

High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance.

Authors: Martinecz, Antal^1,2 (AUTHOR), Boeree, Martin J.³ (AUTHOR), Diacon, Andreas H.^4,5 (AUTHOR), Dawson, Rodney^6,7 (AUTHOR), Hemez, Colin^8,9 (AUTHOR), Aarnoutse, Rob E.¹⁰ (AUTHOR), Abel zur Wiesch, Pia^1,2,11,12 (AUTHOR) pzw@daad-alumni.de

Superior Title: PLoS Computational Biology. 4/13/2023, Vol. 19 Issue 4, p1-23. 23p. 1 Diagram, 2 Charts, 5 Graphs.

Subject Terms: *RIFAMPIN, *TUBERCULOSIS patients, *TREATMENT duration, *TUBERCULOSIS, *BACTERIAL population, *TREATMENT effectiveness

HTML Full Text PDF Full Text

12

Academic Journal

Evaluation of The Hepatoprotective Effect of Plantago major Extract in A Rifampicin-Isoniazid Induced Hepatitis Rat Model.

Authors: Pelapelapon, Allen Albert^1,2, Rohmawaty, Enny³ e.rohmawaty@unpad.ac.id, Herman, Herry⁴

Superior Title: Trends in Sciences. Apr2023, Vol. 20 Issue 4, p1-9. 9p.

Subject Terms: *PLANTAGO, *RIFAMPIN, *HEPATITIS, *HERBAL medicine, *SERUM

PDF Full Text

13

Academic Journal

Facile preparation of sisal–Fe/Zn layered double hydroxide bio-nanocomposites for the efficient removal of rifampin from aqueous solution: kinetic, equilibrium, and thermodynamic studies.

Authors: Negarestani, Mehrdad¹ (AUTHOR) mnegarestani71@yahoo.com, Farimaniraad, Hamidreza² (AUTHOR), Mollahosseini, Afsaneh³ (AUTHOR), Kheradmand, Asiyeh¹ (AUTHOR), Shayesteh, Hadi⁴ (AUTHOR)

Superior Title: International Journal of Phytoremediation. 2023, Vol. 25 Issue 5, p586-597. 12p.

Subject Terms: *LAYERED double hydroxides, *RIFAMPIN, *AQUEOUS solutions, *ADSORPTION capacity, *PHYSISORPTION, *LANGMUIR isotherms, *WATER purification

HTML Full Text PDF Full Text

14

Academic Journal

First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.

Authors: Pieren, Michel¹ (AUTHOR), Gutiérrez-Solana, Ana Abáigar² (AUTHOR), Arbós, Rosa María Antonijoan³ (AUTHOR), Boyle, Gary W⁴ (AUTHOR), Davila, Myriam¹ (AUTHOR), Davy, Maria⁴ (AUTHOR), Gitzinger, Marc^1,5 (AUTHOR), Husband, Lisa⁵ (AUTHOR), Martínez-Martínez, María S⁶ (AUTHOR), Mazarro, Dolores Ochoa⁷ (AUTHOR), Pefani, Eleni⁴ (AUTHOR), Penman, Sophie L⁸ (AUTHOR), Remuiñán, Modesto J⁶ (AUTHOR), Vlasakakis, Georgios⁹ (AUTHOR), Zeitlinger, Markus¹⁰ (AUTHOR), Dale, Glenn E^1,5 (AUTHOR) glenn.dale@bioversys.com

Superior Title: Journal of Antimicrobial Chemotherapy (JAC). Jun2024, Vol. 79 Issue 6, p1353-1361. 9p.

Subject Terms: *RIFAMPIN, *TAU proteins, *PHARMACOKINETICS

Zugang prüfen (DOI)

15

Academic Journal

Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants.

Authors: Rask‐Madsen, Christian¹ (AUTHOR) christian.raskmadsen@sanofi.com, Katragadda, Suresh² (AUTHOR), Li, Mengyao³ (AUTHOR), Ucpinar, Sibel³ (AUTHOR), Chinn, Leslie³ (AUTHOR), Arora, Puneet⁴ (AUTHOR), Smith, Patrick⁵ (AUTHOR)

Superior Title: Clinical Pharmacology in Drug Development. Jun2024, Vol. 13 Issue 6, p590-600. 11p.

Subject Terms: *RIFAMPIN, *QUINIDINE, *BRUTON tyrosine kinase, *PHARMACOKINETICS

Zugang prüfen (DOI)

16

Academic Journal

Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study.

Authors: Imai, Hiromitsu¹ (AUTHOR), Oikawa, Ichiro² (AUTHOR), Koyama, Tetsuya² (AUTHOR) tetsuya_kouyama@eapharma.co.jp, Matsuki, Shunji³ (AUTHOR)

Superior Title: British Journal of Clinical Pharmacology. Jun2024, Vol. 90 Issue 6, p1395-1407. 13p.

Subject Terms: *RIFAMPIN, *DRUG side effects, *ORGANIC anion transporters, *PHARMACOKINETICS, *JAPANESE people, *DRUG interactions

Zugang prüfen (DOI)

17

Academic Journal

Covalent functionalization of graphene oxide with l-lysine for highly sensitive and selective simultaneous electrochemical detection of rifampicin and acetaminophen.

Authors: Sharma, Keshav¹ (AUTHOR), Kumar, Ashish² (AUTHOR), Sharma, Surbhi¹ (AUTHOR), Tripathi, Chandra Shekhar Pati² (AUTHOR) tripathi.csp@bhu.ac.in, Guin, Debanjan¹ (AUTHOR) debanjan.chem@bhu.ac.in

Superior Title: Journal of Applied Electrochemistry. Jun2024, Vol. 54 Issue 6, p1379-1395. 17p.

Subject Terms: *GRAPHENE oxide, *RIFAMPIN, *ACETAMINOPHEN, *ELECTROCHEMICAL sensors, *DETECTION limit, *CYCLIC voltammetry, *ELECTRON transport

Zugang prüfen (DOI)

18

Academic Journal

Evaluation of novel pyridoxal isonicotinoyl hydrazone (PIH) derivatives as potential anti‐tuberculosis agents: An in silico investigation.

Authors: Hossain, Md. Shamim¹ (AUTHOR), Al Abbad, Sanaa S.² (AUTHOR), Alsunaidi, Zainab H. A.² (AUTHOR), Rahman, Shofiur³ (AUTHOR) mrahman1@ksu.edu.sa, Alodhayb, Abdullah N.^3,4 (AUTHOR), Hossain, Md. Mainul¹ (AUTHOR), Poirier, Raymond A.⁵ (AUTHOR) rpoirier@mun.ca, Uddin, Kabir M.¹ (AUTHOR) kabirmuddin@gmail.com

Superior Title: International Journal of Quantum Chemistry. 5/5/2024, Vol. 124 Issue 9, p1-22. 22p.

Subject Terms: *RIFAMPIN, *ACYL carrier protein, *FRONTIER orbitals, *MOLECULAR dynamics, *PROTEIN-ligand interactions, *DENSITY functional theory

Zugang prüfen (DOI)

19

Academic Journal

Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.

Authors: Yunivita, Vycke^1,2 (AUTHOR), Gafar, Fajri^1,3,4 (AUTHOR) fajri.gafar@mail.mcgill.ca, Santoso, Prayudi⁵ (AUTHOR), Chaidir, Lidya^2,6 (AUTHOR), Soeroto, Arto Y⁵ (AUTHOR), Meirina, Triana N⁷ (AUTHOR), Brake, Lindsey Te⁸ (AUTHOR), Menzies, Dick^3,4 (AUTHOR), Aarnoutse, Rob E⁸ (AUTHOR), Ruslami, Rovina^1,2,4 (AUTHOR)

Superior Title: Journal of Antimicrobial Chemotherapy (JAC). May2024, Vol. 79 Issue 5, p977-986. 10p.

Subject Terms: *RIFAMPIN, *MULTIDRUG-resistant tuberculosis, *ISONIAZID, *INDONESIANS, *PHARMACOKINETICS, *PHARMACODYNAMICS

Geographic Terms: INDONESIA

Zugang prüfen (DOI)

20

Academic Journal

Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach.

Authors: Hanley, Michael J.¹ (AUTHOR), Yeo, Karen Rowland² (AUTHOR), Tugnait, Meera³ (AUTHOR), Iwasaki, Shinji⁴ (AUTHOR), Narasimhan, Narayana⁵ (AUTHOR), Zhang, Pingkuan⁶ (AUTHOR), Venkatakrishnan, Karthik⁷ (AUTHOR), Gupta, Neeraj¹ (AUTHOR) neeraj.gupta@takeda.com

Superior Title: CPT: Pharmacometrics & Systems Pharmacology. Apr2024, Vol. 13 Issue 4, p624-637. 14p.

Subject Terms: *RIFAMPIN, *EFAVIRENZ, *DRUG interactions, *ANAPLASTIC lymphoma kinase, *NON-small-cell lung carcinoma, *PHARMACOKINETICS, *CYTOCHROME P-450 CYP3A

Zugang prüfen (DOI)

Narrow Search